Addressing challenges of data management for cosmetic, personal care and over-the-counter products

Oren Cohen, MD

Oren Cohen, MD, is Chief Medical Officer, with responsibility for Fortrea’s medical strategy, scientific leadership, ethics and governance oversight across Fortrea’s portfolio.

Quality

Learn how our systemic approach to quality enables us to deliver on the simple commitment of “right first time” in a complex environment.

Clinical Solutions

Fortrea offers comprehensive healthcare solutions across various specialties. Discover our innovative and tailored solutions for your healthcare needs.

Incorporating sustainability into our clinical research operations

Assessing the implications of Medicare drug price negotiations for drug development sponsors

NICE technology appraisals of oncology treatments

A review of economic modeling approaches, recommendation decisions and potential impact of the new severity modifier.

How Fortrea helped enroll over 5,000 patients 30 days early

When we help a sponsor not only complete enrollment, but complete it 30 days early, we consider it a win worth sharing.

Creating a combined advanced therapy medicinal product as an SME in the EU

Combined advanced therapy medicinal products (CATMPs) have a specific product classification under the European Medicines Agency (EMA).

Dr. Gillespie goes to Capitol Hill to advocate for rare kidney disease

Dr. Barbara Gillespie, Vice President & Therapeutic Strategy Leader at Fortrea, recently participated in “Rare Kidneys on the Hill Day” on July 25th, joining patients, caregivers, physicians and researchers on Capitol Hill to speak with members of Congress and raise awareness about rare kidney disease (RKD).